The store will not work correctly when cookies are disabled.
5-({(S)-[(S)-(4-Methylphenyl)(phenyl)methyl]sulfinyl}methyl)thiazole
ID: ALA4552525
PubChem CID: 155556193
Max Phase: Preclinical
Molecular Formula: C18H17NOS2
Molecular Weight: 327.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc([C@H](c2ccccc2)[S@@+]([O-])Cc2cncs2)cc1
Standard InChI: InChI=1S/C18H17NOS2/c1-14-7-9-16(10-8-14)18(15-5-3-2-4-6-15)22(20)12-17-11-19-13-21-17/h2-11,13,18H,12H2,1H3/t18-,22-/m0/s1
Standard InChI Key: WMJNCYWJEPGMOC-AVRDEDQJSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
21.6872 -21.2304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6860 -22.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3941 -22.4589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1037 -22.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1009 -21.2268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3923 -20.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8121 -22.4570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8134 -23.2742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1050 -23.6823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1059 -24.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8148 -24.9070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5242 -24.4929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5198 -23.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5191 -22.0473 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.2275 -22.4548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9346 -22.0450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6772 -22.3774 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
27.2231 -21.7693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8133 -21.0622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0143 -21.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5179 -21.2301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9794 -20.8220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 1
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
14 7 1 0
14 15 1 1
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
14 21 1 0
1 22 1 0
M CHG 2 14 1 21 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 327.47 | Molecular Weight (Monoisotopic): 327.0752 | AlogP: 4.49 | #Rotatable Bonds: 5 |
Polar Surface Area: 35.95 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.61 | CX LogP: 3.59 | CX LogD: 3.59 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.65 | Np Likeness Score: -0.71 |
References
1. Kalaba P, Ilić M, Aher NY, Dragačević V, Wieder M, Zehl M, Wackerlig J, Beyl S, Sartori SB, Ebner K, Roller A, Lukic N, Beryozkina T, Gonzalez ERP, Neill P, Khan JA, Bakulev V, Leban JJ, Hering S, Pifl C, Singewald N, Lubec J, Urban E, Sitte HH, Langer T, Lubec G.. (2020) Structure-Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters., 63 (1): [PMID:31841637] [10.1021/acs.jmedchem.9b01938] |